Drugs.com: Escitalopram reduces symptoms of anxiety in teens

Outlet covers UC research that points to a possible new treatment for adolescent anxiety

For adolescents with generalized anxiety disorder, UC research has shown that the medication escitalopram could reduce symptoms. The study was published online Aug. 25 in The Journal of Clinical Psychiatry.

Jeffrey Strawn, MD, associate professor and anxiety expert in the Department of Psychiatry and Behavioral Neuroscience at the University of Cincinnati, and colleagues treated adolescents with anxiety disorder with escitalopram or a placebo for eight weeks to see if improvement occurred.

"For clinicians treating anxious adolescents, this study provides preliminary answers to important questions about the effectiveness of this treatment," Strawn says.

Read the full Drugs.com story.

Psych Central also reported on this research.

Read the full UC News release.

Featured photo courtesy of Unsplash.

Next Lives Here

The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.

Related Stories

3

UC Blue Ash takes next step in major renovation project

July 17, 2024

Muntz Hall, the flagship building on the University of Cincinnati Blue Ash College campus, is in the next phase of a major renovation project that will dramatically transform the main entrance, enhance access to student support services and add new spaces for students to study or meet between classes.

Debug Query for this